ArticleCureus2022
Ascites as the Presenting Sign of Systemic Lupus Erythematosus.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- Case Report: An Unusual Cause of Massive Ascites.GE Portuguese journal of gastroenterology · 2026Article
- Article
- Protein-losing enteropathy as the first presentation of systemic lupus erythematosus: A case report from Sudan.Clinical case reports · 2023Article
- A 28-Year-Old Woman Presenting with a Clinical Flare of Systematic Lupus Erythematosus and Abdominal Pain Due to Rectus Sheath Hematoma.The American journal of case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although systemic lupus erythematosus (SLE) can manifest differently in each patient, ascites is a rare first sign. The diagnosis of SLE can be easily missed when the initial presentation is uncommon. A 39-year-old male presented with painless abdominal fullness and was found to have ascites, thrombocytopenia, and anemia. He was initially diagnosed with Evan's syndrome and treated with prednisone. Upon follow-up, he had worsening thrombocytopenia and was found to have a positive antinuclear antibody, anti-double-stranded DNA antibody, and low complement levels consistent with SLE. He was treated with methylprednisolone, intravenous immunoglobulin, and mycophenolate mofetil with improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.